Greene joins Sage as CEO as Jonas swaps to innovation role Eyeing phase 3, Atsena raises $55M financing for blindness gene therapy Neuron23 uncloaks with $113.5M to tackle CNS disorders through genetic mutations Sponsored: Vida Ventures: Powering Breakthroughs in Biopharma Vivace snares $30M to push Hippo-targeting drugs into the clinic Exo Therapeutics snags $25M to handle 'undruggable' enzymes through their exosites Ellume's COVID-19 test nabs first at-home, over-the-counter emergency use authorization Gilead guts its filgotinib plans, dealing a blow to O'Day's diversification dream Featured Story | By Phil Taylor Sage Therapeutics is embarking on a new chapter in its development following its $1.5 billion alliance with Biogen last month, and that challenge will now be met by a new CEO. read more |
| |
|---|
|
| | Admescope acquired by Symeres Admescope’s high-quality and tailored ADME-Tox services complement Symeres’ medicinal chemistry and integrated drug discovery & development services. Together we can advance your projects from hit to clinic. |
Top Stories By Ben Adams University of Florida spinout Atsena Therapeutics has closed a $55 million financing that will help take its gene therapy for a common cause of blindness in children into pivotal trials. read more By Leah Vann Since October 2018, scientists at Neuron23 have worked quietly to find their place in the world of precision medicine. That place is using artificial intelligence and data science to target neurodegenerative and neuroinflammatory diseases in patients with specific genetic mutations. read more Sponsored By: RBC Capital Markets RBC Senior Biotech Analyst Luca Issi interviews Co-Founder of Vida Ventures Arjun Goyal on passion for investing, company purpose, and emerging modalities and investor trends in today’s unique market. read more By Amirah Al Idrus Three years after coming of out stealth, Vivace Therapeutics has raised another $30 million to pursue drugs targeting the Hippo-YAP pathway. The funding, drawn from Boxer Capital, RA Capital Management and Canaan Partners, will push its lead program into the clinic in the first half of 2021. read more By Leah Vann Michael Bruce, Ph.D., has worked for the likes of Pfizer and CRISPR Therapeutics, but now he’s the CEO of what he believes will be the future in medicine: Exo Therapeutics. The company raised $25 million in series A funding to back a pipeline of drugs that bind their enzyme targets at their exosites. read more By Ben Adams Ellume has been given an emergency use authorization for its OTC pandemic test you can take at home. read more By Angus Liu After hitting an FDA roadblock, Gilead Sciences has decided to cut its losses on its Galapagos-partnered rheumatoid arthritis drug Jyseleca, better known as filgotinib. The JAK inhibitor was once a blockbuster hopeful and the poster child of CEO Daniel O'Day's early effort to diversify from its core antiviral portfolio. read more Resources Sponsored By: Metabolon Learn six ways metabolomics provides greater confidence, higher success rates and complements the work of your in-house teams for your drug development pipeline. Sponsored by: ZS Learn how Aerie fueled their product launches with advanced analytics. Sponsored By: Elligo Health Research® Understanding the Challenges COVID-19 Pediatric Clinical Trials Face | White Paper Sponsored By: Thermo Fisher Scientific Lack of resources to move from lab concept to the manufacture/delivery of GMP clinical supplies to patients, key milestones can be missed. Sponsored by: Cytiva Human pluripotent stem cells (PSCs) have huge potential to produce cell therapies for many clinical areas. Here we describe a controlled, automated, and defined manufacturing process to fuel demand. Sponsored by: Covance Download the whitepaper to learn how your safety organization can implement automation technologies to enable process and cost efficiencies, improve resource allocation and ensure compliance and quality. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: BBK Worldwide The BBK Worldwide Study Voices 2020 survey gives voice to the healthcare consumer in the wake of COVID-19 and reveals important insights for clinical trial enrollment and engagement. Sponsored By: BioAnalytix Download this eBook and Learn the Advantages of LC-MS based HCP Profiling for Development of Complex Biologics. Sponsored By: Polpharma Biologics Innovative cell lines and early process development are critical to generate a high producing cell lines alongside a USP strategy to meet high quality standards. Sponsored by: Premier Research Browse the latest learnings and insights from our clinical development professionals. Sponsored by: Rousselot This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Sponsored By: Lonza Liquid-filled hard capsule formulations offer unique options for the manufacture and dosing of highly potent actives. Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Outer Edge Technology Cybercriminals Are Actively Exploiting The Coronavirus Pandemic To Gain Entry To Enterprise Networks. Don’t Let Your Company Become The Next Ransomware Headline -- Make These Changes Now! Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Drug Development Boot Camp® 2021 Onsite and VIRTUAL in real time November 17-18, 2021 | Register now! Pre-Boot Camp preparation is now available. Fierce JPM Week January 11–13, 2021, 10AM ET | Virtual Event | 